Patents in the European Union: An Overview for Foreign Businesses
There is no single EU patent granted centrally. A foreign business protects an invention across Europe mainly through a European patent from the European Patent Office under the European Patent Convention, then validated nationally or as a Unitary Patent, or through individual national patent offices.
Patents in Europe are one of the most misunderstood areas of IP, largely because there is no single "EU patent" granted by a central EU body in the way an EU trade mark is. One distinction matters before anything else: "Europe", in patent terms, is broader than "the European Union". The dominant route, the European patent, runs through the European Patent Office under an international treaty whose membership reaches well beyond the EU and includes states such as the United Kingdom, Switzerland, Turkey, and Norway. A patent is a time-limited exclusive right granted for a new invention that is capable of industrial application, in exchange for publishing how the invention works. In Europe the routes to obtaining that right run through several distinct systems that overlap but are not the same, and conflating them is the most common and most expensive mistake. This page frames how those routes fit together at a high level and points to a detailed walkthrough for the mechanics. It is general information, not legal advice. For anything fact-specific, the sensible course is to consult a vetted local firm.
What a patent protects in Europe
A patent gives its owner the right to stop others making, using, selling, or importing the patented invention without permission, for a limited period and within the territory the patent covers. Protection is tied to what the claims of the granted patent define, not to a general idea or a product as a whole. The scope is the wording of the claims, read in light of the description, so drafting determines what you actually own.
The substantive bar is broadly consistent across Europe: an invention must be new, involve an inventive step (it must not be obvious to a skilled person), and be capable of industrial application. Certain things are excluded under the European Patent Convention, but only as such; the explicit categories include discoveries, scientific theories, mathematical methods, schemes and methods for doing business, and programs for computers. The "as such" qualifier is doing real work: the outcome for software-related and business-method claims turns on whether the claim has technical character, not on a blanket exclusion. The exact treatment of borderline subject matter, software-related and biotech inventions in particular, is technical and turns on the claim wording, so it is worth taking local advice early rather than assuming a US or other foreign patent will translate directly.
Who administers patents: no single EU office
This is the point to get right. Patents in Europe are not administered by a single European Union office, and there is no patent granted by the EUIPO (which handles EU trade marks and designs, not patents). There are three distinct routes, and a foreign business usually combines them rather than choosing one in isolation.
The first is the European patent granted by the European Patent Office (EPO) under the European Patent Convention (EPC). The EPC is an international treaty, not EU law, and its membership is wider than the European Union; a number of EPC contracting states are not EU members. A European patent is examined and granted centrally by the EPO, but on grant it has historically become a bundle of national patents that must each be validated and maintained in the individual countries where the applicant wants protection.
The second is the Unitary Patent, available since 2023 and an EU-level instrument. After the EPO grants a European patent, the proprietor can request unitary effect, which gives a single patent right covering the participating EU member states, enforced through the Unified Patent Court (UPC). Its territorial coverage is fixed at registration: a Unitary Patent covers the states participating at the date it is registered and does not later expand to states that join afterwards. The group of participating states has been growing over time, so a Unitary Patent registered today may cover more states than an earlier one, but an existing right does not grow to reach new joiners. The Unitary Patent does not cover the whole European Union, and it certainly does not cover the whole of the EPC. Do not assume it reaches every EU country or every market where you sell; check the participating states for your generation of right with the EPO.
The third route is the national patent offices. Each country retains its own office through which you can file a purely national patent under domestic law, independent of the EPO. For protection in a single market, or in a country outside your European patent strategy, a direct national filing can be the right tool.
The table below sketches how the three relate. Treat it as orientation only, since the detail and the list of participating states change over time.
| Route | Granting body | Territory | Enforced through |
|---|---|---|---|
| European patent (EPC) | European Patent Office | EPC states you validate in (certain non-EPC states by extension or validation agreement) | UPC for participating EU states unless opted out during the transitional period; otherwise each state's national courts |
| Unitary Patent | EPO grant plus unitary effect | Participating EU states at registration only | Unified Patent Court |
| National patent | National patent office | That one country | That country's national courts |
The broad shape of getting protection
Mechanically, the European patent route follows a familiar arc: you file an application (often claiming priority from an earlier first filing), the EPO carries out a search and publishes the application, substantive examination assesses novelty and inventive step, and if the application succeeds the EPO grants a European patent. At that point you decide how to secure territory: validate the patent nationally in chosen EPC states, request unitary effect for the participating EU states, or do both across different countries.
Foreign applicants frequently reach Europe through the international Patent Cooperation Treaty (PCT) system, which lets you file one international application and defer the choice of countries, entering the European regional phase before the EPO later. For how that international stage works, see our overview of the PCT. Timelines for examination to grant vary considerably with the technology and the EPO's workload, so treat any single figure as indicative only and build margin into commercial plans. The full procedure, including priority claims, the search and examination stages, validation, and the unitary effect request, is covered in the how-to guide.
Keeping protection in force
A patent in Europe generally runs for up to around twenty years from the filing date, subject to payment of periodic renewal (annuity) fees, but confirm the exact term, start point, and any extensions with the EPO or the relevant national office rather than relying on a fixed figure. The important practical point is that the term is not automatic: renewal fees fall due on a recurring basis, and missing one can cause the patent to lapse.
Where the term and the fee structure get more involved is the multi-route picture. A bundle of nationally validated European patents carries separate renewal obligations in each country, on each country's schedule, whereas a Unitary Patent carries a single renewal fee covering its territory. Supplementary protection certificates, an EU-law mechanism granted by national offices (with a retained equivalent in the UK), can in some circumstances extend protection for certain products such as medicines beyond the basic term; because they derive from EU law, their availability differs between EU and non-EU EPC states. The exact fee amounts, deadlines, grace periods, and any extensions are version-specific and country-specific, so confirm current figures with the EPO, the relevant national office, or your local representative rather than relying on a fixed number.
Main practical considerations for a foreign business
Several recurring issues shape how foreign businesses should approach patents in Europe, and they are worth flagging at overview level.
Choosing the route mix: the central decision is which combination of European patent, Unitary Patent, and national filings fits your commercial map. A Unitary Patent simplifies renewals and gives single-court enforcement across participating states, but it also means a single revocation action at the UPC can knock out the whole right. A classical bundle of national validations is more fragmented and more expensive to renew across many countries, but a loss in one country does not automatically affect the others. Markets outside the participating Unitary Patent states still need separate validation or national filing.
The Unified Patent Court question: businesses with European patents should consider the UPC's jurisdiction. For classical (non-unitary) European patents and applications in participating states, the UPC can have jurisdiction unless the patent is opted out, and the opt-out is available only during a transitional period whose length is set by the UPC framework and may change. The opt-out applies to classical European patents and applications, not to Unitary Patents. This is a strategic litigation decision with real consequences for where and how your patent can be attacked or enforced, and it is one to take with qualified advice rather than by default.
Representation and language: representation requirements differ by route, with the EPO, national offices, and the UPC each setting their own rules. Non-resident applicants will in most cases need a qualified professional representative for substantive proceedings before the EPO, though some acts (filing the application itself, for example) are treated differently. Language regimes, translation requirements, and validation formalities differ by route and by country, and they carry hard deadlines, so confirm the precise requirement for your route with a local representative.
Cost timing: a European strategy front-loads decisions. Validation and translation costs, the unitary effect choice, and the spread of national renewals all arrive at predictable points, so mapping the budget across the lifecycle, rather than only to grant, avoids unwelcome surprises.
Because the consequences of each of these points are jurisdiction-specific and often turn on facts, the sensible course before filing in Europe is to consult a vetted local firm to pressure-test your route choice, your UPC position, and your country coverage. For the wider jurisdiction picture, see our European Union hub.
This article is general information and not legal advice. Official requirements, fees, term lengths, and processing times are set by the EPO, the Unified Patent Court framework, and national offices, and they change over time; always confirm current details through official channels or qualified local counsel.